Massive Blood Pressure Drug Recall Over Cancer Risk: A Systemic Crisis
(By: Scripps News Group) Introduction: The Unsettling Scale of Contamination In a worrying echo of earlier pharmaceutical safety crises, over half a million bottles of a widely prescribed blood pressure medication have been recalled nationwide due to contamination with a potentially cancer-causing impurity. Teva Pharmaceuticals USA, Inc., in conjunction with distributor Amerisource Health Services, initiated a voluntary recall of specific lots of Prazosin Hydrochloride capsules . This action, involving more than 580,000 bottles across various strengths, highlights a persistent and systemic challenge facing the global drug manufacturing supply chain, particularly concerning the presence of N-nitroso compounds, commonly known as nitrosamines. Massive Blood Pressure Drug Recall Over Cancer Risk: A Systemic Crisis Prazosin Hydrochloride is an essential medication used primarily to treat high blood pressure (hypertension) by relaxing blood vessels an...